Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| KETOROLAC TROMETHAMINE INJECTION USP | 30MG | LIQUID | Resolved | 2020-06-08 | 2021-03-29 | 116929 |
| KETOROLAC TROMETHAMINE INJECTION USP | 30MG | LIQUID | Resolved | 2019-01-22 | 2019-03-13 | 73188 |
| L-ARGININE HYDROCHLORIDE INJECTION | 250MG | LIQUID | Resolved | 2022-09-02 | 2023-01-19 | 168545 |
| L-ARGININE HYDROCHLORIDE INJECTION | 250MG | LIQUID | Resolved | 2023-03-28 | 2024-02-07 | 188188 |
| L-ARGININE HYDROCHLORIDE INJECTION | 250MG | LIQUID | Resolved | 2021-04-28 | 2022-05-06 | 138151 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2021-12-02 | 2021-12-30 | 150323 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2018-11-26 | 2018-12-05 | 67605 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2018-12-20 | 2019-02-04 | 70256 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2019-03-05 | 2019-06-28 | 77737 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2017-10-27 | 2017-11-19 | 27239 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2022-02-02 | 2022-03-11 | 154106 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2022-03-14 | 2022-04-20 | 156669 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | LIQUID | Resolved | 2022-06-09 | 2022-10-20 | 162363 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | SOLUTION LIQUID | Resolved | 2025-01-13 | 2025-02-11 | 247608 |
| LABETALOL HYDROCHLORIDE INJECTION USP | 5MG | SOLUTION LIQUID | Resolved | 2025-03-03 | 2025-04-01 | 251573 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION LIQUID | Resolved | 2021-12-20 | 2021-12-30 | 151603 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION LIQUID | Resolved | 2022-01-12 | 2022-01-18 | 152589 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION LIQUID | Resolved | 2022-03-14 | 2023-07-28 | 156638 |
| LOXAPAC IM | 50MG | LIQUID | Resolved | 2021-01-18 | 2021-02-01 | 131830 |
| LOXAPAC IM | 50MG | LIQUID | Resolved | 2022-11-28 | 2022-12-12 | 175993 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |